Creative Biolabs, a biotechnology research service provider, has announced the expansion of its complement assay service portfolio to support the development of next-generation complement therapeutics. This move responds to the growing demand for specialized functional assays in complement-targeted drug discovery, where researchers often encounter complexities related to biological pathways, assay optimization, and the need for reproducible data.
The expanded services offer customizable solutions for early discovery and preclinical evaluation, enabling scientists to investigate complement activation mechanisms, assess candidate activity, and generate data that inform candidate selection. Among the offerings, the C3b deposition assay provides a powerful method for analyzing complement activation by measuring C3b deposition, a critical marker in the complement cascade. This assay supports the characterization of complement-targeting antibodies and proteins by delivering quantitative data on pathway regulation and biological activity.
Another key service is the hemolytic inhibition assay, which evaluates the ability of test candidates to inhibit complement-mediated cell lysis. This functional assay allows for comparisons of candidate inhibitory activity under defined experimental conditions, aiding in the assessment of therapeutic potential. Additionally, the company offers individual components activity tests, which enable detailed analysis of specific complement proteins to support mechanistic studies and pathway investigations. These capabilities help researchers evaluate individual components and generate data crucial for understanding complement-modulating strategies.
The expansion reflects Creative Biolabs' commitment to supporting complement-focused research by combining scientific expertise with customized assay solutions. By providing reliable testing solutions, the company aims to reduce research complexity and improve development efficiency for pharmaceutical and biotechnology organizations worldwide.
Researchers interested in these advanced assay services can explore the offerings at Creative Biolabs' complement therapeutics page.
